Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Chlamydia trachomatis samples testing falsely negative in the Aptima Combo 2 test in Finland, 2019.

Rantakokko-Jalava K, Hokynar K, Hieta N, Keskitalo A, Jokela P, Muotiala A, Jokiranta TS, Kuusela R, Sarkkinen H, Aittoniemi J, Vuorinen T, Hakanen AJ, Puolakkainen M.

Euro Surveill. 2019 May;24(22). doi: 10.2807/1560-7917.ES.2019.24.22.1900298.

2.

Correction to: Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.

Nurmi-Lüthje I, Tiihonen R, Paattiniemi EL, Naboulsi H, Pigg S, Sarkkinen H, Kaukonen JP, Toivanen A, Salmio K, Kataja M, Lüthje P.

Osteoporos Int. 2018 Apr;29(4):847-848. doi: 10.1007/s00198-018-4432-x.

3.

Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.

Nurmi-Lüthje I, Tiihonen R, Paattiniemi EL, Naboulsi H, Pigg S, Sarkkinen H, Kaukonen JP, Toivanen A, Salmio K, Kataja M, Lüthje P.

Osteoporos Int. 2018 Apr;29(4):837-845. doi: 10.1007/s00198-017-4344-1. Epub 2017 Dec 19. Erratum in: Osteoporos Int. 2018 Mar 5;:.

4.

Analysis of the costs for the laboratory of flow cytometry screening of urine samples before culture.

Paattiniemi EL, Karumaa S, Viita AM, Kärpänoja P, Mäkelä M, Isojärvi J, Sarkkinen H.

Infect Dis (Lond). 2017 Mar;49(3):217-222. doi: 10.1080/23744235.2016.1239028. Epub 2016 Oct 21.

PMID:
27766919
5.

Rare Detection of the Acinetobacter Class D Carbapenemase blaOXA-23 Gene in Proteus mirabilis.

Österblad M, Karah N, Halkilahti J, Sarkkinen H, Uhlin BE, Jalava J.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3243-5. doi: 10.1128/AAC.03119-15. Print 2016 May. No abstract available.

6.

Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of viridans group streptococci.

Kärpänoja P, Harju I, Rantakokko-Jalava K, Haanperä M, Sarkkinen H.

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):779-88. doi: 10.1007/s10096-013-2012-8. Epub 2013 Nov 8.

PMID:
24202732
7.

Antimicrobial susceptibility testing of Streptococcus pneumoniae and Haemophilus influenzae --internal quality control as a quality tool on a national level.

Kärpänoja P, Nissinen A, Huovinen P, Sarkkinen H; Finnish Study Group for Antimicrobial Resistance, Fire Network.

APMIS. 2013 Jun;121(6):561-8. doi: 10.1111/apm.12021. Epub 2012 Nov 20.

PMID:
23163534
8.

PCR identification of bacteria in blood culture does not fit the daily workflow of a routine microbiology laboratory.

Karumaa S, Kärpänoja P, Sarkkinen H.

J Clin Microbiol. 2012 Mar;50(3):1031-3. doi: 10.1128/JCM.01271-11. Epub 2011 Dec 14.

9.

Screening of urine samples by flow cytometry reduces the need for culture.

Jolkkonen S, Paattiniemi EL, Kärpänoja P, Sarkkinen H.

J Clin Microbiol. 2010 Sep;48(9):3117-21. doi: 10.1128/JCM.00617-10. Epub 2010 Jun 30.

10.

Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Kärpänoja P, Nyberg ST, Bergman M, Voipio T, Paakkari P, Huovinen P, Sarkkinen H; Finnish Study Group for Antimicrobial Resistance (FiRe Network).

Antimicrob Agents Chemother. 2008 Jul;52(7):2480-5. doi: 10.1128/AAC.01118-07. Epub 2008 Apr 28.

11.

Recommended and prescribed symptomatic treatment for acute maxillary sinusitis in Finnish primary care.

Pulkki J, Rautakorpi UM, Huikko S, Honkanen P, Klaukkas T, Mäkelä M, Palva E, Roine R, Sarkkinen H, Huovinen P, Varonen H; MIKSTRA Collaborative Study Group.

Rhinology. 2007 Sep;45(3):197-201.

PMID:
17956017
12.

Implementing guidelines on acute maxillary sinusitis in general practice--a randomized controlled trial.

Varonen H, Rautakorpi UM, Nyberg S, Honkanen PO, Klaukka T, Palva E, Roine R, Sarkkinen H, Mäkelä M, Huovinen P; MIKSTRA Collaborative Study Group.

Fam Pract. 2007 Apr;24(2):201-6. Epub 2007 Jan 20.

PMID:
17237494
13.

Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children.

Koskinen H, Rautakorpi UM, Sintonen H, Honkanen P, Huikko S, Huovinen P, Klaukka T, Palva E, Roine RP, Sarkkinen H, Varonen H, Mäkelä M; MIKSTRA Collaborative Study Group.

Int J Technol Assess Health Care. 2006 Fall;22(4):454-9.

PMID:
16984678
14.

Management of pain in acute otitis media in Finnish primary care.

Pulkki J, Huikko S, Rautakorpi UM, Honkanen P, Klaukka T, Mäkelä M, Palva E, Roine R, Sarkkinen H, Varonen H, Huovinen P; MIKSTRA Collaborative Study Group.

Scand J Infect Dis. 2006;38(4):265-7.

PMID:
16709526
15.

The Antimicrobial Treatment Strategies (MIKSTRA) program: a 5-year follow-up of infection-specific antibiotic use in primary health care and the effect of implementation of treatment guidelines.

Rautakorpi UM, Huikko S, Honkanen P, Klaukka T, Makela M, Palva E, Roine R, Sarkkinen H, Varonen H, Huovinen P; MIKSTRA Collaborative Study Group.

Clin Infect Dis. 2006 May 1;42(9):1221-30. Epub 2006 Mar 30.

PMID:
16586379
16.

Prescription rates and diagnostic patterns are stable: a comparison of high-, medium- and low-prescribing primary care physicians treating community-acquired respiratory tract infections.

Lesitevuo J, Huikko S, Rautakorpi UM, Leistevuo T, Honkanen PO, Klaukka T, Mäkelä M, Palva E, Roine R, Sarkkinen H, Varonen H, Huovinen P; Mikstra Collaborative Study Group.

Scand J Infect Dis. 2005;37(6-7):465-70.

PMID:
16086530
17.

External failures as descriptor of quality in clinical microbiology laboratory services.

Saarela U, Kivinen T, Sarkkinen H.

Clin Chem Lab Med. 2005;43(1):54-63.

PMID:
15653443
18.
19.

Management of acute maxillary sinusitis in Finnish primary care. Results from the nationwide MIKSTRA study.

Varonen H, Rautakorpi UM, Huikko S, Honkanen PO, Klaukka T, Laippala P, Palva E, Roine R, Sarkkinen H, Mäkelä M, Huovinen P; MIKSTRA Collaborative Study Group.

Scand J Prim Health Care. 2004 Jun;22(2):122-7.

PMID:
15255494
20.

An outbreak of gastroenteritis from a non-chlorinated community water supply.

Kuusi M, Klemets P, Miettinen I, Laaksonen I, Sarkkinen H, Hänninen ML, Rautelin H, Kela E, Nuorti JP.

J Epidemiol Community Health. 2004 Apr;58(4):273-7.

21.

Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.

Lyytikäinen O, Rautio M, Carlson P, Anttila VJ, Vuento R, Sarkkinen H, Kostiala A, Väisänen ML, Kanervo A, Ruutu P.

J Antimicrob Chemother. 2004 Apr;53(4):631-4. Epub 2004 Mar 10.

PMID:
15014065
22.

Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav discs.

Kärpänoja P, Nissinen A, Huovinen P, Sarkkinen H.

J Antimicrob Chemother. 2004 Apr;53(4):660-3. Epub 2004 Feb 18.

PMID:
14973151
23.

Invasive group B streptococcal infections in Finland: a population-based study.

Lyytikäinen O, Nuorti JP, Halmesmäki E, Carlson P, Uotila J, Vuento R, Ranta T, Sarkkinen H, Ammälä M, Kostiala A, Järvenpää AL.

Emerg Infect Dis. 2003 Apr;9(4):469-73.

24.

Detection and typing of Campylobacter jejuni and Campylobacter coli and analysis of indicator organisms in three waterborne outbreaks in Finland.

Hänninen ML, Haajanen H, Pummi T, Wermundsen K, Katila ML, Sarkkinen H, Miettinen I, Rautelin H.

Appl Environ Microbiol. 2003 Mar;69(3):1391-6.

25.

Diagnostic tools in respiratory tract infections: use and comparison with Finnish guidelines.

Honkanen PO, Rautakorpi UM, Huovinen P, Klaukka T, Palva E, Roine R, Sarkkinen H, Varonen H, Mäkelä M; MIKSTRA Collaborative Study Group.

Scand J Infect Dis. 2002;34(11):827-30.

PMID:
12578153
26.

[Knowledge into action--follow-up of infectious diseases in the 21st century].

Ruutu P, Lyytikäinen O, Sarkkinen H.

Duodecim. 2002;118(19):2031-7. Finnish. No abstract available.

PMID:
12462809
27.

Nosocomial bloodstream infections in Finnish hospitals during 1999-2000.

Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P; Hospital Infection Surveillance Team.

Clin Infect Dis. 2002 Jul 15;35(2):e14-9. Epub 2002 Jun 18.

PMID:
12087538
28.

[Treatment guidelines help to beat skin infections and respiratory infections].

Sarkkinen H, Mattila K.

Duodecim. 1999;115(19):2135-7. Review. Finnish. No abstract available.

PMID:
11941804
29.

[Malaria death in Finland].

Karjanlahti N, Järvi K, Sarkkinen H.

Duodecim. 1999;115(14):1464-7. Finnish. No abstract available.

PMID:
11912632
30.

Antibiotic use by indication: a basis for active antibiotic policy in the community.

Rautakorpi UM, Klaukka T, Honkanen P, Mäkelä M, Nikkarinen T, Palva E, Roine R, Sarkkinen H, Huovinen P; MIKSTRA Collaborative Study Group.

Scand J Infect Dis. 2001;33(12):920-6.

PMID:
11868766
31.
32.

Lowest Overtone and Combination Levels of DCCI: The Fermi Resonance v3 = 1/v5 = 2.

Sarkkinen H, Ahonen A, Alanko S.

J Mol Spectrosc. 1999 Feb;193(2):396-402.

PMID:
9920714
33.

Different erythromycin resistance mechanisms in group C and group G streptococci.

Kataja J, Seppälä H, Skurnik M, Sarkkinen H, Huovinen P.

Antimicrob Agents Chemother. 1998 Jun;42(6):1493-4.

34.

High-Resolution Infrared Study of the Fundamental Bands of Deuteroiodoacetylene

Sarkkinen H, Tolonen A, Alanko S.

J Mol Spectrosc. 1997 Sep;185(1):15-20.

PMID:
9344789
35.

Four fatal cases of nephropathia epidemica.

Valtonen M, Kauppila M, Kotilainen P, Lähdevirta J, Svartbäck CM, Kosunen O, Nurminen J, Sarkkinen H, Brummer-Korvenkontio M.

Scand J Infect Dis. 1995;27(5):515-7.

PMID:
8588146
36.

Ureaplasma urealyticum infection associated with acute respiratory insufficiency and death in premature infants.

Ollikainen J, Hiekkaniemi H, Korppi M, Sarkkinen H, Heinonen K.

J Pediatr. 1993 May;122(5 Pt 1):756-60.

PMID:
8496757
37.

Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV-transformed mouse cell lines.

Laatikainen A, Sarkkinen H, Syrjänen K, Mäntyjärvi R.

APMIS. 1990 Oct;98(10):909-15.

PMID:
2173935
38.

Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.

Laatikainen A, Karjalainen H, Jägerroos H, Sarkkinen H, Mäntyjärvi R.

Cancer Immunol Immunother. 1990;31(3):164-8.

PMID:
2159847
39.

Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.

Laatikainen A, Karjalainen H, Sarkkinen H, Syrjänen K, Mäntyjärvi R.

Cancer Immunol Immunother. 1990;30(6):351-6.

PMID:
2154331
40.

[First serologically confirmed deaths due to nephropathia epidemica].

Kauppila M, Kotilainen P, Lähdevirta J, Svartbäck CM, Kosunen O, Nurminen J, Sarkkinen H, Salonen EM, Brummer-Korvenkontio M.

Duodecim. 1990;106(15):1103-6. Finnish. No abstract available.

PMID:
1688321
41.

[Efficient management of sepsis: is lysis centrifugation an auxiliary diagnostic technic?].

Katila ML, Sarkkinen H, Takala J, Jägerroos H, Kari A.

Duodecim. 1988;104(20):1614-9. Finnish. No abstract available.

PMID:
3191866
42.

Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.

Mäntyjärvi R, Sarkkinen H, Parkkinen S, Laatikainen A, Ryhänen A, Syrjänen K.

Intervirology. 1988;29(6):311-9.

PMID:
2852654
43.

Tumour-associated antigens in primary mouse fibroblasts induced by transformation with bovine papillomavirus type 1.

Mäntyjärvi RA, Sarkkinen H, Karajalainen H, Parkkinen S, Ryhänen A, Syrjänen K, Jägerroos H, Nurmi T.

Exp Pathol. 1988;35(1):25-33.

PMID:
2852603
44.

Phenotypic transformation of primary mouse fibroblasts by BPV 1 DNA.

Mäntyjärvi R, Sarkkinen H, Parkkinen S, Ryhänen A, Karjalainen H, Syrjänen K, Syrjänen S.

Arch Virol. 1988;100(1-2):17-25.

PMID:
2839131
45.

C reactive protein in the evaluation of febrile illness.

Putto A, Ruuskanen O, Meurman O, Ekblad H, Korvenranta H, Mertsola J, Peltola H, Sarkkinen H, Viljanen MK, Halonen P.

Arch Dis Child. 1986 Jan;61(1):24-9.

46.

Adenoviral diseases in children: a study of 105 hospital cases.

Ruuskanen O, Meurman O, Sarkkinen H.

Pediatrics. 1985 Jul;76(1):79-83.

PMID:
2989764
47.

C-reactive protein in respiratory virus infections.

Ruuskanen O, Putto A, Sarkkinen H, Meurman O, Irjala K.

J Pediatr. 1985 Jul;107(1):97-100. No abstract available.

PMID:
2989473
49.

Identification of respiratory virus antigens in middle ear fluids of children with acute otitis media.

Sarkkinen H, Ruuskanen O, Meurman O, Puhakka H, Virolainen E, Eskola J.

J Infect Dis. 1985 Mar;151(3):444-8.

PMID:
2982961
50.

Rapid diagnosis of adenoviral tonsillitis: a prospective clinical study.

Ruuskanen O, Sarkkinen H, Meurman O, Hurme P, Rossi T, Halonen P, Hänninen P.

J Pediatr. 1984 May;104(5):725-8.

PMID:
6325657

Supplemental Content

Loading ...
Support Center